Predict your next investment

Corporation
HEALTHCARE | Drug Development
hyperiontx.com

See what CB Insights has to offer

Founded Year

2006

Stage

Acq - P2P | Acquired

Total Raised

$156.61M

Valuation

$0000 

About Hyperion Therapeutics

Hyperion Therapeutics is a privately held specialty therapeutics company focused on the development of therapies that address needs in the areas of gastroenterology and hepatology. In partnership with Ucyclyd Pharma, Hyperion is conducting ongoing research and development of HPN-100 for urea cycle disorders, hepatic encephalopathy, and other forms of hyperammonemia.

Hyperion Therapeutics Headquarter Location

601 Gateway Boulevard Suite 200

South San Francisco, California, 94080,

United States

650-745-7802

Latest Hyperion Therapeutics News

Hyperion Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

Jan 25, 2017

Home » Topics » Top 50 Biopharma Products 2011 » Latest News » Hyperion Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 Summary Hyperion Therapeutics Inc Hyperion is a biopharmaceutical company. It develops and commercializes novel drugs for the treatment of orphan diseases and hepatology disorders. Ravicti, the company's first approved product is indicated for use as a nitrogenbinding agent in adult and pediatric patients aged above two years suffering with urea cycle disorders UCDs and those who cannot be treated by dietary protein restriction and amino acid supplementation alone. Ravicti glycerol phenylbutyrate lowers ammonia in the blood. The product is also being developed for a second orphan indication, hepatic encephalopathy HE. Further, the company acquired another product candidate, Buphenyl sodium phenylbutyrate tablets and powder from Ucyclyd Pharma. Hyperion is headquartered in South San Francisco, California, the US. The company aims to support the urea cycle disorder community by enabling access to the drugs at affordable prices. To this end, Hyperion offers support services such as financial support, and insurance coverage to the eligible patients. Hyperion Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Hyperion Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Hyperion Therapeutics is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Hyperion Therapeutics Patents

Hyperion Therapeutics has filed 6 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/21/2013

3/22/2016

Diseases of liver, Hepatology, Inflammations, Esophagus disorders, Syndromes

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

11/21/2013

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

3/22/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Diseases of liver, Hepatology, Inflammations, Esophagus disorders, Syndromes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.